Navigation Links
UofL receives $3.15 million grant from Helmsley Charitable Trust
Date:8/5/2010

The University of Louisville has received a $3.15 million grant from the Leona M. and Harry B. Helmsley Charitable Trust to support the UofL James Graham Brown Cancer Center and cancer research taking place in Owensboro. The grant will be matched with state "Bucks for Brains" funding to bring more than $4.5 million to the Owensboro Cancer Research Program (OCRP).

"When we established this program in partnership with Owensboro Medical Health System (OMHS) in 2006, we envisioned other significant organizations joining us in our effort to create and develop novel approaches to preventing and treating cancer," said Dr. James Ramsey, president of the University of Louisville. "This gift from the Helmsley Trust moves our vision forward and is recognition for the importance of the work taking place here."

"We are excited to see the fine work of the James Graham Brown Cancer Center and Owensboro Medical Health System expand through this public/private initiative," noted John Codey, trustee of the Helmsley Charitable Trust. "The promise of plant-based pharmaceuticals and vaccines to dramatically improve healthcare at reduced cost is both exciting and critically important."

The grant and state matching funds will be used to create an endowed faculty position for a nationally recognized researcher in plant-based pharmaceuticals, as well as creating two new faculty members to expand and enhance the research program.

The tobacco-based process involves inserting genes needed for drug development into the tobacco genome. The leaves are then harvested, processed and purified to derive a key ingredient.

Projects underway at OCRP include, but are not limited to, the development of a plant-based vaccine to prevent HIV, understanding how changes in the calcium-signaling pathway of stem cells impacts the development and continued growth of lung cancer cells, as well as determining whether the interaction of the heavy metal cadmium with tobacco-derived carcinogens contributes to the development of lung cancer in smokers.

"Plant-based pharmaceutical systems have a number of advantages," said Dr. Donald Miller, director of the James Graham Brown Cancer Center. "The costs for starting materials are low, which translates into a lower production cost. The materials are readily available, meaning that we are able to increase production levels relatively quickly. Additionally, plant-based therapies have fewer issues with potential contamination than those utilizing other materials such as animal or human pathogens."

The collaboration between UofL and OMHS is greatly enhanced because of Kentucky BioProcessing (KBP), located in Owensboro. KBP is a world leader in the development and execution of scalable processes for commercial scale production of plant-made pharmaceuticals. Established by OMHS in 2006, KBP has developed a network of relationships with leading PMP researchers from across the globe.

"We have a tremendous amount of resources in the Owensboro region to assist in the research to develop new therapies to prevent or treat cancer," said Jeff Barber, Dr. PH, president and chief executive officer of OMHS. "It is exciting that we have the opportunity to develop cancer cures that could someday benefit patients around the globe."

The Owensboro Cancer Research Program is devoted to unlocking the potential of plant-made pharmaceuticals. The research and drug development program takes advantage of the natural products and agricultural industries in the Owensboro region to address diseases impacting the area, especially those that are tobacco-related. Ultimately, the partnership's goal is to create less expensive drugs for cancer prevention and treatment.

Right now researchers with the James Graham Brown Cancer Center and OCRP are working to develop a second-generation cervical cancer vaccine grown in tobacco plants in order to make it affordable to millions of women worldwide. A vaccine of this type will be most beneficial in women in rural parts of the United States, India and Sub-Saharan Africa.


'/>"/>

Contact: Lauren Williams
lauren.williams@louisville.edu
502-852-7461
University of Louisville
Source:Eurekalert

Related medicine news :

1. St. Michaels receives prestigious grants to study trauma
2. Doctor at Cincinnati Childrens receives prestigious NIH MERIT Award
3. Research consortium at CHLA receives $410,000 to study leukemia and lymphoma
4. Keck School of Medicine of USC receives $24 million gift from Sumner M. Redstone
5. UC San Diego receives major clinical and translational science award
6. Lu receives grant from Research to Prevent Blindness organization
7. Childrens National Medical Center receives first NIH CTSA given to a childrens hospital
8. WPI computer science professor receives HP Labs Innovation Research Award
9. USF receives patent for technology to improve treatment for neurodegenerative diseases
10. Quincy Bioscience Receives Patent for Jellyfish Protein Aequorin
11. Childrens Hospital Los Angeles oncologist receives $50,000 Hyundai Scholar Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body care ... announced the company had a successful visit to the 2017 ECRM Diet, Vitamin & ... that work in the nutritional, sports and health industries a chance to meet in ...
(Date:1/20/2017)... Florida (PRWEB) , ... January 20, 2017 , ... Lice ... head lice cases in families with school-aged children since the holiday season. , ... the holidays with their families, sharing hugs and taking photos, which is the head-to-head ...
(Date:1/20/2017)... ... ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in a ... has been life-saving as she has been on the trial for more than six ... ovarian cancer in 2009. She underwent standard chemotherapy but a year later went to ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Mary Magdalene: ... the mysterious life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace ... denizen, who spent her career as an educator interacting with countless women who had ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “I Forgive You”: a fine examination of ... Forgive You” is the creation of published author, Stephen Miller, who, for over ten long ... gracefully given to him. Born in Trinidad and Tobago, he has been serving the Lord ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017 Report Details ... Alzheimer,s ... Leading Companies – our new study reveals trends, R&D ... and events affecting the Alzheimer,s disease therapeutics and diagnostics ... these key questions: - How is the Alzheimer,s disease ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor ... market is expected to grow at a CAGR of 27.1% ... 38.7% in the second half of the forecast period. The market ... to 2027. The market is estimated at $1,058 million in 2016, ... ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology: